The subcellular dynamics of RNA stabilizing molecule in response to inflammation

February 1, 2018, Osaka University
Model of inflammatory response by Arid5a/Regnase-1. Regnase-1 localizes to the cytoplasm. Arid5a is imported to the nucleus via an importin-α/β1 pathway. In response to inflammation, the Toll-like receptor (TLR) is activated by LPS, and Il6 mRNA is induced by NF-κB. After that, Arid5a interacts with Il6 mRNA and is exported to the cytoplasm. Credit: M. Higa, Osaka University

A research group at Osaka University revealed the regulatory mechanism of subcellular localization of Arid5a in response to inflammation. It has been known that an inflammatory accelerator is localized in the nucleus, and an inflammatory brake is localized in the cytoplasm.

Tadamitsu Kishimoto (Professor, Immunology Frontier Research Center (IFReC), Osaka University) and histheir research group revealed the of subcellular localization of Arid5a in response to . It has had been known that an inflammatory accelerator, Arid5a, is localized in the , and an inflammatory brake, regnase) , is localized in the . In this study, they showed that 1) Arid5a translocates to the cytoplasm from the nucleus in response to inflammation, 2) bimax, which inhibits cNLS-dependent nuclear import via high-affinity interactions with NLS-binding sites of importin-α, inhibits the nuclear import of Arid5a, and 3) a CRM1 inhibitor, Leptomycin B, inhibits the nuclear export of Arid5a after LPS stimulation.

Macrophages produce inflammatory cytokines to activatee other immune cells and to exclude pathogens. However, over- or chronic inflammation causes diseases including a or autoimmunity. Therefore, the group has been studiedstudied the control mechanism of inflammation, especially focusing on the posttranscriptional regulation of the Il6 mRNA by Arid5a and Regnase-1. Their previous study showed that Arid5a binds to Il6 mRNA 3′UTR to inhibit Regnase-1-mediated

RNA decay. Additionally, Arid5a deficient mice showed down-regulated inflammatory cytokine production, resistance to septic shock, and bleomycin-induced lung injury. Although Arid5a is known to play an important role in immune regulation, whether and how Arid5a subcellular localization impacts immune regulation has remained unclear.

The group showed that Arid5a translocates from the nucleus to the cytoplasm after LPS stimulation. Since the inhibition of Arid5a nuclear export causes the significant suppression of IL-6 production, further understanding of Arid5a dynamics may lead to novel therapeutic strategies of for septic shock or autoimmune diseases.

Explore further: Effect of gut bacteria on specific immune cells underlies persistent liver inflammation

More information: Mitsuru Higa et al. Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a, Proceedings of the National Academy of Sciences (2018). DOI: 10.1073/pnas.1719921115

Related Stories

Effect of gut bacteria on specific immune cells underlies persistent liver inflammation

January 16, 2018
Persistent liver inflammation in sufferers of chronic viral hepatitis is likely caused by interactions between pro-inflammatory immune cells in the liver and products from gut bacteria, according to new work involving A*STAR ...

Role of transcriptional co-factor hints at possible inflammatory bowel disease treatment

December 12, 2017
Inflammatory bowel disease (IBD), including the two conditions ulcerative colitis and Crohn's disease, results in long-term inflammation of the gut and is associated with dysregulation of the immune system. However, it is ...

Innate lymphoid cells play an important role in regulation of intestinal inflammation

August 28, 2017
The intestine contains an extensive and diverse microbial biome, a population that includes potential pathogens and dietary antigens that need to be tolerated. Dysregulation of mucosal responses may cause a loss of tolerance, ...

New understanding of chronic lung inflammatory diseases unfolding

March 23, 2017
Researchers studying chronic inflammation that can lead to the development of lung diseases such as asthma, pulmonary fibrosis, and cancer, are focusing on the role cytokines play in regulating the behavior of fibroblast ...

How cytoplasmic DNA triggers inflammation in human cells

October 17, 2017
A team led by LMU's Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in ...

Novel role for spleen B cells in inflammatory response to bacterial toxins

May 9, 2016
The inability to adequately respond to infection can cause a whole-body state of inflammation known as sepsis. This can eventually lead to systemic inflammatory response syndrome (SIRS), and even death. White blood cells ...

Recommended for you

A new mechanism in the control of inflammation

October 18, 2018
After infection or tissue injury, the inflammatory immune response attacks the infection and repairs the damaged tissue. However, sometimes excess inflammation can have the opposite effect, increasing injury in a process ...

Sugar, a 'sweet' tool to understand brain injuries

October 15, 2018
Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies.

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

Microbiome profiling reveals associations with ulcerative colitis severity, treatment

October 11, 2018
A study of gut microbes from more than 400 children points to how the microbiome behaves in this inflammatory bowel disease.

Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression

October 4, 2018
Crohn's disease is a lifelong condition characterized by a fluctuating course of gastro-intestinal inflammation with repeated flares and remissions. Any part of the alimentary tract from the mouth to the anus can be affected ...

Immune system's balancing act keeps bowel disease in check

October 2, 2018
Australian researchers have uncovered clues in the immune system that reveal how the balance of 'good' gut bacteria is maintained. The information could help in the prevention and treatment of inflammatory bowel disease (IBD).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.